Ep 236: 3 Updated Guidelines for Neuromuscular Blocking Agents

Even in 2023, residual paralysis from neuromuscular blocking agents (NMBA) is still a problem. Recently a task force developed by the ASA released guidelines for the reversal of NMBA. Jeremy and Sass examine these guidelines and talk about what they mean for current anesthesia practice.

Read More